(Clinical Chemistry. 1998;44:1701-1712.)
© 1998 American Association for Clinical Chemistry, Inc.
Earning your keep: succeeding in laboratory reimbursement
Donald S. Young
 |
Introduction
|
|---|
The seventh Clinical Chemistry Forum of the American Association
for Clinical Chemistry was held in Baltimore, Maryland, on December 4
and 5, 1997. Clinical Chemistry Fora have been oriented to addressing
the management issues affecting clinical chemists and the clinical
laboratory field. In this way, they complement the AACC's targeted
conferences on new technology (Oak Ridge) and applications (A.O.
Beckman). The theme for the 1997 Forum was reimbursement under the
difficult conditions imposed by compliance with the new regulations
associated with documentation of medical necessity for provided
services. The Forum brought together representatives of the government
as well as the independent and hospital clinical laboratory industries.
As part of its objective of disseminating information to the many
members of the AACC and other scientists who were not able to attend
the Forum, the AACC is pleased to publish here a summary of the
presentations delivered at the meeting. These were compiled from a
transcript of the presentations as well as the handout material
provided by the speakers. In addition to the 13 summaries, the full
texts of the presentations by Dr. Charles Root and Dr. Thomas Hoerger
are included. I accept responsibility for the summaries, which were not
reviewed by the authors. They do not reflect the overall excellence of
the meeting or the extensive interaction between the speakers and the
audience, which created the exciting forum that was the intent of the
meeting.
 |
HCFA's Perspective
|
|---|
In her presentation, Juliette Jenkins of the Laboratory Policy
Division, Health Care Financing Administration
(HCFA),1
provided the following information about how her agency is
helping to implement the changes in Medicare documentation requirements
mandated by the Balanced Budget Act of 1997 (BBA).
Section 1862 of the Social Security Act requires that Medicare pay only
for reasonable and necessary tests and services; Section 1833e of the
Social . . . [Full Text of this Article]
 |
Carrier/Intermediary Perspective
|
|---|
 |
The Commercial Laboratory Perspective
|
|---|
 |
The Outlook for Hospitals
|
|---|
 |
Ambulatory Payment Classifications: What the Future Holds for
Laboratories
|
|---|
 |
Medicare Part B Reimbursement
|
|---|
 |
The New ICD-10 Codes: What You Need to Know
|
|---|
 |
How to Bid, Evaluate, and Implement a Capitated Contract
|
|---|
 |
Practical Tips for Surviving under Managed Care
|
|---|
 |
What are Managed Care Organizations Looking For from
Laboratories?
|
|---|
 |
Fraud and Abuse: The Enforcer's Perspective
|
|---|
 |
Medicare AuditsTwo Stories: An Inspector's and the Inspected
Laboratory's
|
|---|
the inspector
 |
Medicare AuditsTwo Stories: An Inspector's and the Inspected
Laboratory's
|
|---|
the laboratory
 |
Footnotes
|
|---|
Copyright © 1998 by the American Association for Clinical Chemistry.